Amylobarbitone sodium interviews with schizophrenic patients

Five non-schizophrenic patients who did not normally exhibit thought disorder were given intravenous amylobarbitone sodium. All of them showed thought disorder while under the influence of the drug. The value of this method in the diagnosis of schizophrenia appears diminished by these observations.